Cargando…
LncRNA-AC068228.1 Is a Novel Prognostic Biomarker That Promotes Malignant Phenotypes in Lung Adenocarcinoma
BACKGROUND: The crucial roles played by lncRNA-AC068228.1 in primary malignant cancer remain poorly understood. This study aimed at examining the clinical significance and evaluating the biological function of AC068228.1 in lung adenocarcinoma (LUAD). METHODS: We used data obtained from The Cancer G...
Autores principales: | Jiang, Xiulin, Chen, Min, Du, Junyi, Bi, Hong, Guo, Xiang, Yang, Chao, He, Xu, Jin, Zhixian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904746/ https://www.ncbi.nlm.nih.gov/pubmed/35280807 http://dx.doi.org/10.3389/fonc.2022.856655 |
Ejemplares similares
-
LncRNA-AC02278.4 Is a Novel Prognostic Biomarker That Promotes Tumor Growth and Metastasis in Lung Adenocarcinoma
por: Chen, Xin, et al.
Publicado: (2022) -
Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
por: Li, Xinyan, et al.
Publicado: (2022) -
Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator
por: Li, Xinyan, et al.
Publicado: (2022) -
Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
por: Jiang, Xiulin, et al.
Publicado: (2022) -
Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)